Overview

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To evaluate 18F-FDOPA PET obtained from PET/CT or PET/MRI imaging in patients with newly diagnosed or recurrent gliomas.
Phase:
N/A
Details
Lead Sponsor:
Erik Mittra
Collaborator:
National Cancer Institute (NCI)
Treatments:
Dihydroxyphenylalanine